Research, Charts & Company Announcements
Research Tree provides access to ongoing research coverage, media content and regulatory news on COUNTRYWIDE PLC. We currently have 4 research reports from 2 professional analysts.
|13Feb17 09:40||RNS||Holding(s) in Company|
|07Feb17 14:00||RNS||Director/PDMR Shareholding|
|20Jan17 09:45||RNS||Holding(s) in Company|
|19Jan17 15:45||RNS||Holding(s) in Company|
|18Jan17 12:30||RNS||Holding(s) in Company|
|16Jan17 11:15||RNS||Holding(s) in Company|
|13Jan17 07:00||RNS||Trading Statement|
Frequency of research reports
Research reports on
Chill for agents, spring in housing volumes
24 Nov 16
Yesterday’s Autumn Statement appears to be: good for 'alternative' housing providers, UK-focused contractors and materials producers; potentially problematic for mainstream housebuilders; and bad news especially for lettings-dominated agents. Chancellor Philip Hammond’s key spending measures included an additional £3.7bn funding to boost new housing volumes and £1.1bn for roads. Shares in estate agents, however, have fallen in response to the threat to ban them from charging fees to tenants.
Panmure Morning Note 31-07-15
31 Jul 15
We have made further cuts to earnings and dividend estimates partly on the back of the disappointing interim figures and also to reflect higher costs and depreciation charges given the ambitious plans announced to double the business over the period to 2020. While the shares have sold off 4%, lower earnings estimates leaves them trading on a full PE of 14x for the current year. We remain on a hold with a 570 target.
Panmure Morning Note 30-07-15
30 Jul 15
First half PBT of £28.9m was below expectations. Transaction volumes fell by 12% as H1 was adversely affected by the election. The outlook for the housing looks better for the second half though affordability is an increasing issue. We have already taken our FY15 forecasts down in anticipation. The current year PE is 13.8x. We are retaining our hold recommendation and 570p target.
Panmure Morning Note 16-07-15
16 Jul 15
Assuming lower interim profits owing to the election impact, we have cut our forecasts for FY15 by 7% bringing them close to consensus. If there is a strong enough rebound in the second half this may be conservative. The shares are down 10% in the last month and trade on 11.9x FY16 revised earnings. We retain our Hold recommendation and 570p price target given the favourable longer term outlook for the housing market.
21 Feb 17
Lighthouse Group* (LGT): Middle Britain growth (CORP) | Utilitywise* (UTW): Double-digit sales growth (CORP) | Trakm8* (TRAK): Earnings expectations cut again (CORP) | dotDigital* (DOTC): Myriad growth opportunities (CORP) | Artilium* (ARTA): Five-year Telenet deal secured and prepaid (CORP) | Netcall* (NET): Cloud investment pays off (CORP)
Industry fundamentals remain positive
21 Feb 17
The Biotech Growth Trust (BIOG) is a specialist vehicle, aiming to generate long-term capital growth via investment in global biotech stocks. Following a particularly volatile period for the biotech industry, where concerns about drug pricing and investor risk aversion have weighed heavily on stock prices, the managers are hopeful that greater clarity regarding US healthcare policy will lead to continued improved performance of biotech stocks. Industry fundamentals remain attractive, including continued innovation and valuations are very supportive, which offers the potential for higher industry merger and acquisition activity.
Small Cap Breakfast
16 Feb 17
Saffron Energy—Schedule One update. Raising £2.5m, expected Mkt Cap £7.7m. Admission due 24 Feb. Italian Oil & Gas Play Guinness Oil & Gas Exploration—Publication of prospectus. Seeking to raise £50m and invest in 15 exploration companies at launch, with plans to grow the portfolio to 30 positions during its lifetime. Issue closing 23 Feb. Arix Bioscience — Intention to float on the main market from the global healthcare and life science Company supporting medical innovation. Raised £52m in Feb 16 with investors including Woodford Investment Management
Middle Britain growth
21 Feb 17
The Company has achieved our 2017 estimate in 2016 with EBITDA of £2.2m, up 37% on 2015. We upgrade our estimates by 10% at the EBITDA level in 2017. If the shares traded even at the lower end of comparators, they would trade at 17p. We expect the share price to reach our upgraded 17p price target in the short term. Few companies enjoy the unique positioning which Lighthouse has to benefit from the assets of Middle Britain.
13 Feb 17
Surface Transforms* (SCE): H1 results confirm operational progress (CORP) | Premaitha Health* (NIPT): European diagnostics partnership (CORP) | Lok'nStore* (LOK): Filling existing stores, developing new ones (CORP) | Victoria* (VCP): Entry into the European flooring market (CORP) | eg solutions* (EGS): Exceptional H2 performance (CORP)
N+1 Singer - Morning Song 21-02-2017
21 Feb 17
Abzena (ABZA LN) Contract bookings strong; US costs higher than expected | City of London Investment Group (CLIG LN) Earnings and interim dividend in line, some modest growth in FuM | dotdigital Group (DOTD LN) Good H1; broadening avenues of growth | Grafenia (GRA LN) Weak print volumes | Vernalis (VER LN) Interims highlight increasing Tuzistra™ scrip volume